Canadian Online Pharmacy

CDER New February 7, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

February 6, 2014


New and Generic Drug Approvals

February 5, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Disulfiram disulfiram Tablet; Oral Roxane Approval
Doxercalciferol doxercalciferol Injectable; Injection Sandoz Inc Approval
Fludeoxyglucose F-18 fludeoxyglucose f-18 Injectable;Injection Washington Univ Sch Medicine Approval
Fludeoxyglucose F-18 fludeoxyglucose f-18 Injectable;Injection Essential Isotopes Llc Approval
Ilevro nepafenac Suspension/Drops;Ophthalmic Alcon Res Ltd Manufacturing Change or Addition
Levonorgestrel; Ethinyl Estradiol levonorgestrel; ethinyl estradiol Tablet; Oral Haupt Pharma Approval
Morphine Sulfate morphine sulfate Solution; Oral Caraco Approval
Phentermine Hydrochloride phentermine hydrochloride Capsule; Oral Invagen Pharms Approval
Phentermine Hydrochloride phentermine hydrochloride Tablet; Oral Invagen Pharms Approval
Pylera bismuth subcitrate potassium; metronidazole; tetracycline Capsule;Oral Aptalis Pharma Us Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery